EGFR mutation, immumohistochemistry (IHC) and chromogenic in situ hybridization (CISH) as predictors of sensitivity to erlotinib and gefitinib in patients (pts) with NSCLC Meeting Abstract


Authors: Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Hussain, S.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
Abstract Title: EGFR mutation, immumohistochemistry (IHC) and chromogenic in situ hybridization (CISH) as predictors of sensitivity to erlotinib and gefitinib in patients (pts) with NSCLC
Meeting Title: 41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 16 Suppl.
Meeting Dates: 2005 May 13-17
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-06-01
Start Page: 628S
Language: English
ACCESSION: WOS:000230326604148
PROVIDER: wos
Notes: --- - Meeting Abstract: 7031 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos"
MSK Authors
  1. Sanaa Hussain
    16 Hussain
  2. William Pao
    141 Pao
  3. Vincent Miller
    259 Miller
  4. Marc Ladanyi
    861 Ladanyi
  5. Gregory J Riely
    344 Riely
  6. Maureen F Zakowski
    275 Zakowski
  7. Mark Kris
    597 Kris
  8. Robert T Heelan
    79 Heelan